Mechanism of anti-D-mediated immune suppression - A paradox awaiting resolution?

Trends in Immunology

Volumn 22, Issue 1, 2001, Pages 26-31

  Kumpel, Belinda M ^a   Elson, Christopher J ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; FC RECEPTOR; IDIOTYPIC ANTIBODY; RHESUS D ANTIBODY;

B LYMPHOCYTE; CELL DESTRUCTION; CELL FUNCTION; CROSS LINKING; DRUG CLEARANCE; DRUG EFFECT; DRUG MECHANISM; ERYTHROCYTE; FETUS MORTALITY; HUMAN; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; MORBIDITY; NEWBORN HEMOLYTIC DISEASE; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; RECEPTOR BLOCKING; REVIEW; RHESUS INCOMPATIBILITY;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; PREGNANCY; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM;

EID: 0034924494     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(00)01801-9     Document Type: Review

References (56)

1. Beiträge zur immunitätslehre
2. RhD hemolytic disease of the newborn
3. Prevention of Rh-haemolytic disease: Results of the clinical trial. A combined study from centres in England and Baltimore
4. The Rh blood group system: A review
5. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis
6. The introduction of human monoclonal anti-D for therapeutic use
7. Clearance of Rh D-positive red cells with monoclonal anti-D
8. Monoclonal immunoglobulin anti-D for prevention of hemolytic disease of the new-born
9. Assessment of in vivo function of IgG1 and IgG3 monoclonal anti-D by clearance of Tc99 labelled autologous Rhesus D positive red blood cells
10. - volunteers
11. + red cells
12. Cross-linking of B lymphocyte Fcγ receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis
13. Inhibitory receptors abound?
14. Antigen receptor tail clue
15. FcR-mediated inhibition of cell activation and other forms of coinhibition
16. Monitoring the clearance of fetal RhD-positive red cells in FMH following immunoglobulin administration
17. Mechanism of Rh prophylaxis: An experimental study on specificity of suppression
18. Failure of passively administered anti-Rh to prevent secondary responses
19. Prevention of Rh isoimmunization. Progress report of the clinical trial in mothers
20. Reduced severity of Rh-haemolytic disease after anti-D immunoglobulin
21. Superclustering of B cell receptor and FcγRIIB1 activates Src homology 2-containing protein tyrosine phosphatase-1
22. Molecular cloning and primary structure of Kell blood group protein
23. Removal of incompatible cells by the spleen
24. Clearance of Rh positive cells by low concentration of Rh antibody
25. FcγRII-B1 regulates the presentation of B cell receptor-bound antigens
26. Identification of alloreactive T-cell epitopes on the Rhesus D protein
27. Clearance of erythrocytes and the immune response. An experimental study
28. Genetic control of the humoral immune response to rabbit erythrocyte isoantigens
29. Antibody-mediated immune suppression to the Rh factor: Animal models suggesting mechanism of action
30. An animal model for hemolytic disease of the fetus and newborn in New Zealand White and New Zealand Red rabbits
31. A
32. Competition of 19S and 7S antigen receptors in the regulation of the primary immune response
33. Efficient IgG-mediated suppression of primary antibody responses in Fcγ receptor-deficient mice
34. 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression
35. Augmented humoral and anaphylactic responses in FcγRII-deficient mice
36. Cellular camouflage: Fooling the immune system with polymers
37. A transforming growth factor β-like immunosuppressive factor in immunoglobulin G-binding factor
38. Transforming growth factor-β1 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines
39. Histidine-rich glycoprotein regulates the binding of monomeric IgG and immune complexes to monocytes
40. Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells
41. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity
42. Species-specific variation in glycosylation of IgG: Evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics
43. 125I-labelled anti-γ globulin in the determination of the number of D antigen sites on red cells of different phenotypes
44. The estimation of the concentration and equilibrium constant of anti-D
45. 0(D) immune response in male volunteers
46. Joint working group of the British Blood Transfusion Society and the RCOG. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis
47. Blood groups in rabbits
48. A
49. Antibody-mediated suppression of the immune response is determinant specific
50. Role of the Fc fragment in the regulation of the primary immune response
51. Immunoregulation by monoclonal sheep erythrocyte-specific IgG antibodies: Suppression is correlated to level of antigen binding and not to isotype